ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Retail Trade

cocokara fine, Inc.

Business Summary

Cocokara Fine is a provider of healthcare services to drug store and pharmaceutical operation.

Financial Highlights

Mar 2021 JPYUSD
Revenue366,440M3,455.10M
Gross Profit105,153M991.47M
Operating income10,349M97.57M
Income before tax7,480M70.52M
Net income4,320M40.73M
EBITDA14,886M140.35M
Diluted EPS144.031.35
Dividends Per Share920.86
Total Assets203,407M1,840.78M
Total liabilities61,896M560.14M
Total equity141,508M1,280.61M
Operating cash flow2,251M21.22M
Currency in JPYCurrency in USD

Historical Data

 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 377,203M 390,963M 400,559M 403,875M 366,440M
Gross Profit 93,564M 101,205M 104,914M 108,098M 105,153M
Operating income 10,140M 13,665M 12,905M 13,338M 10,349M
Income before tax 11,339M 14,638M 13,795M 12,971M 7,480M
Net income 7,037M 9,067M 9,158M 8,270M 4,320M
EBITDA 14,162M 17,641M 16,870M 17,863M 14,886M
Diluted EPS 286.79 376.38 381.24 344.05 144.03
Dividends Per Share 70 73 76 92 92
Total Assets 146,963M 158,177M 172,727M 208,298M 203,407M
Total liabilities 63,723M 70,365M 77,644M 68,642M 61,896M
Total equity 83,237M 87,810M 95,081M 139,653M 141,508M
Operating cash flow 9,381M 17,117M 9,388M 12,919M 2,251M
 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 3,483.34M 3,527.51M 3,612.06M 3,714.62M 3,455.10M
Gross Profit 864.03M 913.13M 946.06M 994.22M 991.47M
Operating income 93.63M 123.29M 116.37M 122.67M 97.57M
Income before tax 104.71M 132.07M 124.39M 119.30M 70.52M
Net income 64.98M 81.80M 82.58M 76.06M 40.73M
EBITDA 130.78M 159.16M 152.12M 164.29M 140.35M
Diluted EPS 2.64 3.39 3.43 3.16 1.35
Dividends Per Share 0.64 0.65 0.68 0.84 0.86
Total Assets 1,318.88M 1,487.32M 1,560.52M 1,929.48M 1,840.78M
Total liabilities 571.86M 661.63M 701.48M 635.83M 560.14M
Total equity 746.98M 825.66M 859.02M 1,293.62M 1,280.61M
Operating cash flow 86.63M 154.44M 84.65M 118.82M 21.22M

Valuation Measures

Mar 2021
PER59.08
ROA2.09%
ROE3.07%
Operating margin2.82%
Profit margin1.17%

Key executives

  • President & Representative Director: Atsushi Tsukamoto
  • Manager-Finance: Hiroshi Sato
  • Executive Officer & Manager-Information Technology: Yasuyuki Oike
  • Senior Manager-Compliance & Manager-Legal Affairs: Masafumi Morita
  • Director, VP & Head-Business Administration: Tsuyoshi Yamamoto

Shareholders

    Contact Details

    Related Companies

    • Medical Support YK
    • Well Support YK
    • E Well YK
    • Cocokara Fine Board Incentive Plan
    • CFIZ Co. Ltd.
    • KikoMedical Corp.
    • Miyabi Pharmacy Co., Ltd.
    • Futatsuka Holdings KK
    • Yakuho Shoji YK
    • Flight YK
    • Koishikawa Pharmacy KK
    • K S YK
    • Cocokara Fine Employee Incentive Plan
    • Senior Cosmos Co., Ltd.
    • Toho Chozai YK
    • cocokarafine soleil Co. Ltd.
    • Yamamoto Service KK
    • Shanghai Cocokara Fine, Inc.
    • Cocokara Fine Next Co., Ltd.
    • cocokarafine associe, Inc.
    • cocokara fine OEC, Inc.
    • Cocokara fine Healthcare, Inc.
    • I System KK (Yamaguchi)
    • Kojido Corp.
    • Kusuri No Ebina YK
    • Finecare, Inc.
    • Kodama Co., Ltd. (Niigata)
    • Reha Works YK
    • Medical Index YK
    • Aianju KK

    Competitors

    • Welcia Holdings Co., Ltd.
    • Medical System Network Co., Ltd.
    • Sugi Holdings Co., Ltd.
    • TSURUHA Holdings, Inc.
    • Pharmarise Holdings Corp.
    • COSMOS Pharmaceutical Corporation
    • Sundrug Co., Ltd.
    • MatsukiyoCocokara & Co.
    • Nihon Chouzai Co., Ltd.
    • Ain Holdings Inc.
    • Qol Holdings Co., Ltd.
    Last Updated on 1 Oct, 2021

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more